搜尋結果
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
百濟神州(BeiGene)將在第64屆美國血液學會年會上展示其血液腫瘤臨床開發項目動態進展
PR Newswire Asia· 1 年前大會所接受的報告材料將展示百濟神州針對B細胞惡性腫瘤和髓系白血病所開展的廣泛而深入的臨床開發項目 15篇被大會接受的摘要中包括涉及重磅的BTK抑制劑百悅 ...